A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
This study focuses on a medicine called sotatercept, which is being tested to treat Pulmonary Arterial Hypertension (PAH). PAH makes blood vessels in the lungs thick and narrow, causing high blood pressure in the lungs and making the heart work harder. This can lead to breathlessness and difficulty with daily activities. While current treatments help symptoms, they don't always stop PAH from getting worse. Sotatercept is a new type of treatment that targets specific proteins involved in causing PAH. This particular study is for people who have already used sotatercept in previous studies. Its main goal is to see how safe the medicine is over a longer period and if people can take it alongside their regular PAH medicines without too many problems.
एक नजर में
यह अध्ययन किस बारे में है?
Researchers are always looking for better ways to treat Pulmonary Arterial Hypertension (PAH). This is a condition where the blood vessels in your lungs become thick and narrow, making it difficult for blood to flow through them. This causes high blood pressure in your lungs and puts a lot of strain on your heart. People with PAH often find themselves short of breath and struggle with physical activity.
Currently, there are treatments that help with the symptoms of PAH, but they don't always stop the condition from worsening. This study is looking at a new medicine called sotatercept. Sotatercept is different because it's a 'targeted therapy.' This means it's designed to work specifically on certain proteins in your body that are thought to play a role in developing PAH.
This study is a 'long-term follow-up' study. This means it's for people who have already participated in other clinical trials for sotatercept. The main aim is to carefully monitor the safety of sotatercept over a longer period. Researchers also want to understand if people can comfortably take this medicine alongside their current, standard PAH treatments without experiencing too many side effects or difficulties.
मुख्य निष्कर्ष
- This study is for patients who have previously used sotatercept medicine for PAH.
- It aims to find out if sotatercept is safe to use long-term with other PAH medicines.
- Sotatercept is a targeted treatment for managing PAH.
- You will need to attend regular check-ups if you join the study.
- भागीदारी स्वैच्छिक है, और आप किसी भी समय वापस ले सकते हैं।.
कौन पात्र हो सकता है?
This study is specifically designed for people who have already taken part in previous studies testing sotatercept for PAH. If you didn't participate in one of those earlier studies, you won't be able to join this one.
To be considered, you must have completed your previous sotatercept study without dropping out early. You also need to be able to understand and agree to all the study requirements, including attending all scheduled visits. It's important to note that if you missed many doses of sotatercept between your last study and the start of this one (more than four doses), you might not be able to participate.
There are also some reasons why you wouldn't be able to join. For example, if you are currently pregnant or breastfeeding, or if you are already participating in another medical study for a different experimental medicine. If you or an immediate family member works on this study, you also wouldn't be eligible to take part.
क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?
यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.
- Have you already participated in a sotatercept study for PAH?
- Did you complete your previous sotatercept study without dropping out early?
- क्या आप 18 वर्ष या उससे अधिक आयु के हैं?
- क्या आप वर्तमान में गर्भवती हैं या स्तनपान करा रही हैं?
- Are you able to attend all required study appointments?
- Are you currently participating in another medical study for a different experimental drug?
भागीदारी में क्या शामिल है?
This is a long-term study that involves continuing to take the study medicine, sotatercept, alongside your usual PAH treatments. The study team will regularly check your health and how you're responding to the treatment. This will include attending scheduled clinic visits, likely involving physical examinations, blood tests, and other assessments to monitor your condition and ensure your safety. The exact number and frequency of visits, as well as the total duration you will be in the study, will be explained in detail by the study team. You will be expected to follow all instructions for taking the medicine and attending appointments.
संभावित जोखिम और लाभ
Locations (137)
- Pulmonary Associates, PA ( Site 1008)सत्यापित पोस्टकोडफीनिक्स, संयुक्त राज्य अमेरिका
- Arizona Pulmonary Specialists ( Site 1010)सत्यापित पोस्टकोडस्कॉट्सडेल, संयुक्त राज्य अमेरिका
- University of Arizona ( Site 1006)सत्यापित पोस्टकोडटक्सन, संयुक्त राज्य अमेरिका
- University of California San Diego Health ( Site 1002)सत्यापित पोस्टकोडला जोला, संयुक्त राज्य अमेरिका
- UC Irvine Health Medical Center ( Site 1086)सत्यापित पोस्टकोडऑरेंज, संयुक्त राज्य अमेरिका
- UC Davis - Medial Center ( Site 1064)सत्यापित पोस्टकोडसैक्रामेंटो, संयुक्त राज्य अमेरिका
- UCSF Helen Diller Medical Center at Parnassus Heights ( Site 1019)सत्यापित पोस्टकोडसैन फ्रांसिस्को, संयुक्त राज्य अमेरिका
- Jeffrey S. Sager, MD Medical Corporation ( Site 1060)सत्यापित पोस्टकोडसांता बारबरा, संयुक्त राज्य अमेरिका
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ( Site 1028)सत्यापित पोस्टकोडटोरेंस, संयुक्त राज्य अमेरिका
- University of Colorado Hospital ( Site 1013)सत्यापित पोस्टकोडऑरोरा, संयुक्त राज्य अमेरिका
- George Washington University Medical Faculty Associates ( Site 1025)सत्यापित पोस्टकोडवॉशिंगटन डी.सी., संयुक्त राज्य अमेरिका
- Mayo Clinic Jacksonville ( Site 1045)सत्यापित पोस्टकोडजैक्सनविल, संयुक्त राज्य अमेरिका
सामान्य प्रश्न
What is PAH?
PAH stands for Pulmonary Arterial Hypertension. It's a condition where the blood vessels in your lungs become narrow, causing high blood pressure in your lungs and making your heart work harder.
What is sotatercept?
Sotatercept is a new medicine being tested to treat PAH. It's designed to target specific proteins that play a role in causing the condition.
इस अध्ययन में कौन शामिल हो सकता है?
This study is only for people who have previously taken part in other clinical trials for sotatercept for PAH.
यह अध्ययन महत्वपूर्ण क्यों है?
This study helps researchers understand the long-term safety of sotatercept and how well it works alongside other PAH treatments over a longer period.
Can I stop being part of the study if I want to?
हाँ, आप किसी भी समय, किसी भी कारण से अध्ययन छोड़ने का निर्णय ले सकते हैं, और यह आपके नियमित चिकित्सा देखभाल को प्रभावित नहीं करेगा।.
और अधिक जानने के लिए कैसे पता करें
किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.
चर्चा
समुदाय चर्चा
हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.